USPTO serial 79214760
ID-NET ABC 123
Reviewed by CopyMark Law Group
Reg. 5624624Status 709
- Filing date
- Status date
- Registration date
- Dec 11, 2018
- Examiner
- TAYLOR, DAVID T
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ID-NET ABC 123?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
INTERNATIONAL DRUG DEVELOPMENT INSTITUTE, en abrégé "IDDI"
BE
Other trademarks owned by INTERNATIONAL DRUG DEVELOPMENT INSTITUTE, en abrégé "IDDI"
INTERNATIONAL DRUG DEVELOPMENT INSTITUTE, en abrégé "IDDI"
BE
Other trademarks owned by INTERNATIONAL DRUG DEVELOPMENT INSTITUTE, en abrégé "IDDI"
INTERNATIONAL DRUG DEVELOPMENT INSTITUTE, en abrégé "IDDI"
BE
Other trademarks owned by INTERNATIONAL DRUG DEVELOPMENT INSTITUTE, en abrégé "IDDI"
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michelle P. Ciotola
Michelle P. Ciotola Cantor Colburn LLP20 Church Street22nd FloorHartford, CT 06103Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computer software for data management and statistics in the field of clinical trials for pharmaceuticals, pharmaceutical drug development and pharmaceutical product evaluation; calculating machines, data processing equipment, computers; software in connection with the management of clinical trials for pharmaceutical products | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services, namely, design, planning and conducting of clinical trials and analysis of clinical data in the field of clinical trials for pharmaceuticals, pharmaceutical drug development and pharmaceutical product evaluation; design and development of computer hardware and software relating to the management of clinical trials for pharmaceuticals; rental of software relating to the management of clinical trials for pharmaceuticals; rental of software in connection with the management of clinical trials for pharmaceutical products | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by INTERNATIONAL DRUG DEVELOPMENT INSTITUTE, en abrégé "IDDI"
- Other trademarks owned by INTERNATIONAL DRUG DEVELOPMENT INSTITUTE, en abrégé "IDDI"
- Other trademarks owned by INTERNATIONAL DRUG DEVELOPMENT INSTITUTE, en abrégé "IDDI"
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named ID-NET ABC 123
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 27, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 27, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 27, 2025 | C71T | CANCELLED SECTION 71 | — |
| Dec 11, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 19, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 19, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 19, 2023 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| May 19, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 19, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 19, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 10, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 19, 2019 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Mar 19, 2019 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Mar 11, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 11, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 25, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 25, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 21, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 5, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 5, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 5, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 20, 2018 | ALIE | ASSIGNED TO LIE | — |
| Aug 7, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 7, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 7, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 7, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 7, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 3, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 3, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 3, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 5, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 5, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 5, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 29, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 11, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 11, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 6, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 5, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 29, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 25, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 25, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 24, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |